Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease.
作者信息
Zoldan J, Friedberg G, Weizman A, Melamed E
机构信息
Department of Neurology, Beilinson Medical Center, Petah Tiqva, Israel.
出版信息
Adv Neurol. 1996;69:541-4.
PMID:8615178
Abstract
摘要
Zotero 插件